Clinuvel Pharmaceuticals Ltd. revenue for the last year amounted to 54.83 M USD, the most of which — 52.16 M USD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 45.35 M USD. The greatest contribution to the revenue figure was made by Europe & United States — last year it brought Clinuvel Pharmaceuticals Ltd. 48.14 M USD, and the year before that — 41.50 M USD.